Physician profile
Michael Bruno
NPI 1861902058
$798.90
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $402 · 2024: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $135.71 | 2023-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $82.63 | 2023-2024 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $74.86 | 2023-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $67.61 | 2023-2024 | Farxiga |
| W. L. Gore & Associates, INC. | $64.19 | 2023-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis |
| Novartis Pharmaceuticals Corporation | $62.37 | 2023-2024 | |
| Pfizer INC. | $49.07 | 2023-2024 | |
| Abbott Laboratories | $46.29 | 2024 | Navitor |
| Lexicon Pharmaceuticals, INC. | $45.96 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $41.67 | 2023-2024 | |
| Alnylam Pharmaceuticals INC. | $31.24 | 2023-2024 | Onpattro |
| Philips North America LLC | $24.03 | 2024 | (Cm9) Amb Mon & Diag Und |
| Irhythm Technologies, INC. | $22.97 | 2024 | Zio Monitor, Zio Xt Patch |
| Esperion Therapeutics, INC. | $19.15 | 2024 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.74 | 2024 | Jardiance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $14.41 | 2023 | Evkeeza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bruno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.